TrialHuman vaccines & immunotherapeutics2022

Safety and immunogenicity of a quadrivalent, inactivated, split-virion influenza vaccine (IIV4-W) in healthy people aged 3-60 years: a phase III randomized clinical noninferiority trial.

Xiaoyuan Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.